抄録
DAY 1 THURSDAY, MARCH 03, 2022
- 15:30 Opening
MC: Maria Ruriko Umano, DIT, Center for Clinical Sciences, NCGM Japan
- 15:33 – 15:35 Opening Remarks
Norihiro Kokudo (President, NCGM)
- 15:35 –15:40 Global Platform for Medical Innovation as an Academic Research Organization
Tatsuo Iiyama (Director, DIT, Center for Clinical Sciences, NCGM Japan)
Session 1 Clinical Research Institutes Cases Studies “Sharing experience on setting up a framework for clinical trials”
- 15:40 –15:55 Preclinical trial of COVID-19 vaccine in cynomolgus macaques in Thailand: Opportunity and challenge
Suchinda Malaivijitnond (Director, National Primate Research Center of Thailand-Chulalongkorn University)
- 15:55-16:10 Experience in vaccine clinical trials in Indonesia-an industrial perspective
Mas Rahman Roestan,(Operational Director, PT Bio Farma (Persero), Indonesia)
- 16:10-16:25 Setting up clinical trial in resource-limited contexts: challenges and current status (Thailand)
Kulkanya Chokephaibulkit (Director, Siriraj Institute of Clinical Research SiCRES, Mahidol University)
- 16:30-16:50 Panel discussion + Q/A
Moderator: Marlinang Siburian, DIT, Center for Clinical Sciences, NCGM Japan
- 16:50- 17:05 The Mycetoma Research Center, University of Khartoum experience on Clinical Trials.
Ahmed Hassan Fahal, Director of the MRC, University of Khartoum, Soudan
- 17:05- 17:20 Securing the Health of the Filipino for the Next Millennium:
Setting up the Philippine National Institutes of Health's Clinical Trials and Translation
Eva Maria Cutiongco-de la Paz (Vice Chancellor for Research, University of the Philippines Manila;
Executive Director of the National Institutes of Health)
- 17:20- 17:35 Toward lymphatic filariasis elimination by Mass triple-drug administration:
a clinical trial in a resource-limited setting.
Taniawati Supali (Head of Helminthology Division. Department of Parasitology
Faculty of Medicine Universitas Indonesia)
- 17:35- 17:50 Challenging with Informed consent in African remote area.
Tona Lutete (Head of Clinical Pharmacology and Pharmacovigilance unit, University of Kinshasa.
Head of the National Pharmacovigilance Center in DRCongo)
- 17:50- 18:20 Panel discussion +Q/A
Moderator: Muchanga Sifa, DIT, Center for Clinical Sciences, NCGM Japan
- 18:20 Closing
DAY 2 FRIDAY, MARCH 04, 2022
-
15:30-15:35 Brief of day 1
MC: Marlinang Siburian, DIT, Center for Clinical Sciences, NCGM Japan
Session 1 International Clinical trials collaboration from ASEAN and Africa “Sharing on study collaboration”
Moderator: Marlinang Siburian, DIT, Center for Clinical Sciences, NCGM Japan
-
15:35 -15:50 Public-Private partnerships in TB, is still relevant today?
Charles Y. Yu, Vice chancellor for Research, De La Salle Medical and Health Sciences Institute.
-
15:50-16:05 Phase I of NDV-HXP-S Clinical Trial in Thailand
Punnee Pitisuttithum, Acting Head of the Vaccine Trial Centre,
Faculty of Tropical Medicine, Mahidol University, Thailand
- 16:05-16:20 Development of Ebanga (mAb114) as a treatment for Ebola virus disease in DR Congo
Sabue Mulangu, Senior Vice President of Global Medical Affairs at Ridgeback Bio.USA
Professor of Immunology at the Medical School at University of Kinshasa;
Head of Immunology Department Institut National des Recherches Biomedicales, INRB, DRCongo,
-
16:20-16:35 Leading the international clinical trial collaboration for nutrition and health in Indonesia
with high quality results: opportunities and challenges.
Rina Agustina, Head of Human Nutrition Research Center,
Indonesian Medical Education and Research Institute (HNRC-IMERI), Faculty of Medicine Universitas Indonesia
-
16:35-16:40 Break
Session 2 International Clinical trials collaboration from Japan and the USA “Sharing on research collaboration related matters”
-
16:40-16:55 Infectious diseases in developing countries (Haiti and Indonesia);
Attempts to utilize genome technologies for better disease control
Fujihiko Minamoto, Clinical Laboratory Technologist,
Department of Computational Biology and Medical Sciences, Tokyo University
-
16:55 -17:10 Academic Research Organization International collaboration, ARISE
Miwa Sonoda, DIT, Center for Clinical Sciences, NCGM Japan
-
17:10-17:25 Development of a competency assessment framework for clinical research professionals
Barbara E Bierer, Director, MRCT Center of Brigham and Women’s Hospital,
Professor of Medicine, Harvard Medical School.
-
17:25- 17:40 International collaboration in capacity building for clinical trial professionals.
Muchanga Sifa, DIT, Center for Clinical Sciences, NCGM Japan
-
17:40 – 18:20 Panel discussion +Q/A
Moderator: Maria Ruriko Umano, DIT, Center for Clinical Sciences, NCGM Japan
- 18:20 Closing
Masato Ichikawa, DIT, Center for Clinical Sciences, NCGM Japan
